OPENING OF BANKRUPTCY

IRIDM

Export PDF

Company — Opening of bankruptcy.

Financial year 2021 · Closed on 30/06/2021

Net result-1,2 k €-706,1 %over 1 year

Gross margin-1,2 k €-507,5 %over 1 year

Equity-32,1 k €-9,4 %over 1 year

Identity

Source · BCE/KBO

IRIDM is a Public limited company incorporated in 2002. Its registered office is in Leuven.

Legal situation: Opening of bankruptcy
BCE/KBO no. / VAT: BE 0477.573.461
Incorporation: 22/05/2002
Legal form: Public limited company
Registered office: Kapeldreef 60 box 25
3001 Leuven · FlandreSee on map
Contributed capital: 460 000,00 €
Latest accounts: 30/06/2021

Financials

Source · NBB, 13 filings

Trend over 13 financial years

	2021		2019		2017		2016		2015
Income statement
Gross margin	-1,2 k €	-507%	287,3 €	+124%	-1,2 k €	+0.4%	-1,2 k €	0.0%	-1,2 k €
EBITDA	-1,2 k €	-706%	193,1 €	+112%	-1,6 k €	+1.6%	-1,6 k €	+18.5%	-1,9 k €
Operating result	-1,2 k €	-706%	193,1 €	+112%	-1,6 k €	+1.6%	-1,6 k €	+18.5%	-1,9 k €
Net result	-1,2 k €	-706%	193,1 €	+112%	-1,6 k €	+1.6%	-1,6 k €	+19.8%	-2 k €
Balance sheet
Equity	-32,1 k €	-9.4%	-29,3 k €	-5.0%	-27,9 k €	-5.9%	-26,4 k €	-6.4%	-24,8 k €
Total assets	4,2 k €	-27.5%	5,8 k €	-21.8%	7,5 k €	-17.5%	9 k €	-14.6%	10,6 k €
Cash	4,2 k €	-27.5%	5,8 k €	-21.8%	7,5 k €	-17.5%	9 k €	-14.6%	10,6 k €
Debts	36,3 k €	+3.3%	35,1 k €	-0.7%	35,4 k €	-0.1%	35,4 k €	+0.1%	35,4 k €

Board of directors

Source · NBB, accounts to 30/06/2021

2 active · 2 ended

Active mandates

Director	Mandates in this company	Period	Other mandatescurrentendedstruck offbankruptcies
W. LUYTEN0476.737.479Represented by Walter Luyten	Directorsince 08/05/2002
Liliane Schoofs	Directorsince 21/06/2012

Ended mandates

Director	Mandates in this company	Period	Other mandatescurrentendedstruck offbankruptcies
Koenraad Debackere	Director08/05/2002 → 2012 accounts
Pharma DM0473.394.147Represented by Koenraad Debackere	Director08/05/2002 → 2010 accounts

Other companies at this address

Kapeldreef 60 3001 Leuven

Company	CBE no.
AINIGMA Technologies● Active	0758.652.836
Astracite● Active	1024.012.568
Bart Tech Instruments● Active	1043.392.574
Belgische Vereniging voor Oppervlaktetechnieken van Materialen● Active	0411.562.783
BLOONICS LABS● Active	0748.661.044
Celes● Active	1016.891.877
Comité Européen des Traitement de Surfaces● Active	0827.987.545
DEDA TECHNOLOGY● Active	1012.265.373
DetNet Europe● Active	1036.409.069
DOVEGRAY DIGITALS● Active	1010.131.175
ELECTRA IC● Active	1024.937.929
Evren Technology● Active	1022.160.858
FLEXIBLE ROBOTIC SOLUTIONS● Bankrupt	0534.835.729
FORCE & BROTHERS CONSULTANCY - BELGIUM● Active	1018.498.713
HAMURLABS● Active	1008.980.934
Hit Dynamix Belgium● Active	1025.734.814
HITSOFT CONSULTANCY● Active	1002.545.478
INECT● Active	0746.693.330
INNOVATIE- EN INCUBATIECENTRUM K.U. LEUVEN● Active	0436.325.794
Investigrate● Active	0777.865.665

Full financial information

Source · NBB

	2021	2019	2017	2016	2015	2014
Type of account	Micro model	Micro model	Micro model	Abridged model	Abridged model	Abridged model
Start of the financial year	01/07/2020	01/07/2018	01/07/2016	01/07/2015	01/07/2014	01/07/2013
Closing of the financial year	30/06/2021	30/06/2019	30/06/2017	30/06/2016	30/06/2015	30/06/2014
Length of the financial year	12 months	12 months	12 months	12 months	12 months	12 months
Filing date	25/02/2022	24/02/2020	27/02/2018	30/01/2017	01/02/2016	27/02/2015
General meeting	14/09/2021	10/09/2019	12/09/2017	13/09/2016	08/09/2015	28/12/2014
Currency of the financial year	EUR	EUR	EUR	EUR	EUR	EUR
NBB quality label	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls

Financial ratios

Source · NBB

Looking for more information about this company?

Try for free

Annual accounts filings

Source · NBB, 13 filings

Model	Closing	General meeting	Filed	Language	Document
Micro model	30/06/2021	14/09/2021	25/02/2022	Dutch	PDF
Micro model	30/06/2019	10/09/2019	24/02/2020	Dutch	PDF
Micro model	30/06/2017	12/09/2017	27/02/2018	Dutch	PDF
Abridged model	30/06/2016	13/09/2016	30/01/2017	Dutch	PDF
Abridged model	30/06/2015	08/09/2015	01/02/2016	Dutch	PDF
Abridged model	30/06/2014	28/12/2014	27/02/2015	Dutch	PDF
Abridged model	30/06/2013	29/10/2013	31/01/2014	Dutch	PDF
Abridged model	30/06/2012	28/10/2012	25/02/2013	Dutch	PDF
Abridged model	30/06/2011	29/10/2011	29/03/2012	Dutch	PDF
Abridged model	30/06/2010	28/10/2010	16/02/2011	Dutch	PDF
Abridged model	30/06/2009	28/12/2009	30/01/2010	Dutch	PDF
Abridged model	30/06/2008	28/12/2008	26/01/2009	Dutch	PDF
Abridged model	30/06/2007	20/11/2007	25/01/2008	Dutch	PDF

Indicative valuation

The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.

Discover the Business plan

Disclaimer

Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.

Board of directors

Source · NBB, accounts to 30/06/2021

2 active · 2 ended

Active mandates

Director	Mandates in this company	Period	Other mandatescurrentendedstruck offbankruptcies
W. LUYTEN0476.737.479Represented by Walter Luyten	Directorsince 08/05/2002
Liliane Schoofs	Directorsince 21/06/2012

Ended mandates

Director	Mandates in this company	Period	Other mandatescurrentendedstruck offbankruptcies
Koenraad Debackere	Director08/05/2002 → 2012 accounts
Pharma DM0473.394.147Represented by Koenraad Debackere	Director08/05/2002 → 2010 accounts

Ownership and network

Looking for more information about this company?

Try for free

Belgian Official Gazette publications

Source · Belgian Official Gazette

Mandates03/01/2014
Ontslag & benoeming zaakvoerder
PDF
Registered office14/02/2008
MAATSCHAPPELIJKE ZETEL
PDF
Mandates18/09/2006
MAATSCHAPPELIJKE ZETEL - ONTSLAGEN - BENOEMINGEN
PDF
Capital / shares22/05/2003
KAPITAAL - AANDELEN - ALGEMENE VERGADERING - STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, )
PDF

Similar companies

A company's peers, by sector and size, are included in the Business plan.

See the Business plan

Timeline

Source · CBE, NBB annual accounts

Year

Identity

Incorporation

Name

Registered office

Annual accounts

Filings13 filings

Mandates

W. LUYTEN

Liliane Schoofs

Pharma DM

Koenraad Debackere

2002200320042005200620072008200920102011201220132014201520162017201820192020202120222023202420252026

IRIDM

No data

Director

CurrentPlanned, not yet servedEndedAccounts filedToday

Registered offices

Source · NBB annual accounts, CBE

Registered address	Period	Source
Kapeldreef 60 bte 25, 3001 HeverleeCurrent		CBE

Company names

Source · NBB annual accounts, CBE

Name	Period	Source
IRIDMCurrent	accounts 2007 → 2021	Accounts 2021 · 2022-06800040

Events

2021
Annual accounts 2021-1,2 k €↓
2019
Annual accounts 2019193,1 €↑
2017
Annual accounts 2017-1,6 k €↑
2016
Annual accounts 2016-1,6 k €↑
2015
Annual accounts 2015-2 k €↓
2014
Annual accounts 2014-1,3 k €↑
2013
Annual accounts 2013-1,5 k €↓
2012
Annual accounts 2012-1,3 k €↓
2011
Annual accounts 20116,7 k €↓
2010
Annual accounts 20106,8 k €↑
2009
Annual accounts 2009-1,2 k €↑
2008
Annual accounts 2008-1,7 k €↓
2007
Annual accounts 2007259,7 k €
22/05/2002
IncorporationPublic limited company

IRIDM

Overview

Identity

Financials

Board of directors

Other companies at this address

Financials

Full financial information

Financial ratios

Annual accounts filings

Valuation

Indicative valuation

Directors & structure

Board of directors

Ownership and network

Publications

Belgian Official Gazette publications

Similar companies

Similar companies

Timeline

Timeline

Registered offices

Company names

Events